SlideShare a Scribd company logo
D.9 Drug Design
By: Sam,
Rob, and
 Farah




             1
D.9 Drug Design
By: Sam,
Rob, and
 Farah




             1
D.9.1 Discuss the use of a compound library in drug
    design.

• A compound library is a collection of stored chemicals, typically used
  in drug discovery high-throughput screening and industrial
  manufacturing.
• Each chemical has all of its chemical information like its chemical
  structure, chemical properties, and physical properties, stored in a
  database.
• If a pharmaceutical chemist is in need of a chemical to perform a
  particular function, he or she can search the electronic compound
  library database.
• This eliminates the synthesizing and the individual evaluation in the
  laboratory of a large number of related compounds. Large numbers of
  related compounds can be created quickly.
• This approach saves money and time.
D.9.2 Explain the use of combinatorial and parallel
   chemistry to synthesize new drugs.

• Combinatorial Chemistry
• Combinatorial chemistry involves the rapid synthesis
  or computer simulation of a large number of different
  but structurally related molecules or materials.
• Used to synthesize a large number of different
  compounds.
• Produces an electronic database or combinatorial
  library.
• Used to mass produce drugs by two solid-phase
  synthesis.
D.9.2 Explain the use of combinatorial and parallel
    chemistry to synthesize new drugs.


Solid-Phase Synthesis
• Starting material is covalently bonded to small polystyrene
  beads
• The beads are reacted with one another and then split and
  reacted with new substances to make new combination of
  molecules
• Produced a wide range of molecules
• The products are then purified by filtering of the beads and
  washing
• Used to build proteins (polypeptides)
• This method is fully automated and uses robotics
D.9.2 Explain the use of combinatorial and parallel
    chemistry to synthesize new drugs.


• Sets of individual compounds are then prepared
  simultaneously by reacting with a number of different reagents
  in arrays of physically separate reaction vessels or micro-
  compartments w/o interchange of intermediates during the
  assembly process
• This allows a smaller, more focused library than that obtained
  with comb. chemistry
• First step towards producing larger yields of materials
  identified from screening tests
• They can then be fully characterized w/o need for huge and
  laborious identification procedures
D.9.2 Explain the use of combinatorial and parallel
      chemistry to synthesize new drugs.

Parallel Synthesis
• Used to produce smaller, more focused compound
    libraries
•   An alternative technique to complement combinatorial
    chemistry
•   Still uses solid-phase chemistry but on a larger scale
    than comb. chemistry
•   Advantage: all intermediates and products are generated
    separately
•   Involves a synthesis of a highly reactive intermediates
D.9.3 Describe how computers are used in Drug
   Design


• It would be impossible to test millions of molecules in a
  lab against any given target, but the computerized
  screening process helps in designating a small set of
  molecules that can then be tested in a wet lab.
• “In-Silico Drug Design” is a series of methods in
  which the computer assists in the identification and
  development of medicine and drugs. There are several
  methods, each with a different purpose/ application
D.9.3 Describe how computers are used in Drug
     Design

They include:
 Molecular Docking and Virtual Screening: the ability to predict binding
  conformations and affinities of millions of molecules without the need of
  a single synthetic step
 Molecular Dynamics: the prediction of the evolution of molecular
  systems over time, the study of protein conformation, protein-protein
  interactions, the simulation of biological membranes.
 Quantum Mechanics: the study of chemical reactions, the effects of
  substitutions on electronic properties and reactivity of molecules
 QSAR: Quantitative structure-activity relationship. The ability of
  predicting biological properties of molecules without even the need of
  knowing their target
 Homology Modeling: predicting the structures of proteins that has not
  been yet crystallized
D.9.3 Describe how computers are used in Drug
   Design


• One example is the
  CSIR Bio-Suite
  • The Indian CSIR
    (Council for
    Scientific and
    Industrial Research)
    developed the “Bio-
    Suite”
     • a software tool to aid
       in the drug discovery
       process.
D.9.4. Discuss how the polarity of a molecule can be
   modified to increase its aqueous solubility and how this
   facilitates its distribution around the body


• Most medicines/drugs are fairly complex organic
  molecules with low polarity.
  • Tend to be insoluble in water and other polar
      environments in the body, which greatly limits their
      capacity as a medicine.
  •   To increase solubility, they can be administered as an
      ionic salt.
D.9.4. Discuss how the polarity of a molecule can be
   modified to increase its aqueous solubility and how this
   facilitates its distribution around the body

• If the molecule
  contains amines, then
  they can be converted
  into their hydrochloride
  acid
• This can be seen in the
  reaction of ammonia
  and hydrochloric acid.
D.9.4. Discuss how the polarity of a molecule can be
    modified to increase its aqueous solubility and how this
    facilitates its distribution around the body

• An example of such a
  drug is Fluoxetine
  Hydrochloride, more
  commonly known as
  Prozac
• The opiates contain an
  amine group and can
  therefore be administered
  as their hydrochloride salt.
D.9.4. Discuss how the polarity of a molecule can be
    modified to increase its aqueous solubility and how this
    facilitates its distribution around the body

• Another example is
  Diamorphine (Heroine)
• The white powder is
  actually Diacetylmorphine
  hydrochloride, making it
  soluble and possible to
  inject into the body.
D.9.4. Discuss how the polarity of a molecule can be
    modified to increase its aqueous solubility and how this
    facilitates its distribution around the body

• The same concept applies to drugs
  that contain a carboxylic acid
  group. These drugs can be made
  polar by converting them into
  their anion and administering
  them as a sodium or calcium salt.
• Take soluble aspirin for example.
  The anion of aspirin enters the
  body and returns to its unionized
  form once it has reached a strong
  acidic part of the body (the
  stomach)
D.9.5 Describe the use of chiral auxiliaries to form the
        desired enantiomer.

• Traditionally, the synthesis of an optically active compound normally
  produces a racemic mixture of the two enantiomers. The mixture has to
  be separated into the two isomers.
• Recently, a technique using chiral auxiliaries has made it possible to
  synthesize just the desired isomer.
• A chiral auxiliary is an optically active chemical compound or unit that
  is temporarily incorporated into organic synthesis so that it can be
  carried out asymmetrically with the selective formation of one of two
  enantiomers.
• This is useful as enantiomers have identical chemical properties in
  relation to non-chiral reagents and cannot therefore be easily chemically
  separated.
• However, because of the different properties of enantiomers in
  biochemical reactions, separation is vital.
D.9.5 Describe the use of chiral auxiliaries to form the
   desired enantiomer.




• The chiral auxiliary attaches itself to the non-chiral molecule to
  create the stereochemical conditions necessary to force the reaction to
  follow a certain path.
• Once the new molecule has been formed, the auxiliary can be taken
  off (recycled) to leave the desired enantiomer.
D.9.5 Describe the use of chiral auxiliaries to form the
   desired enantiomer.



• Taxol is an anti-
  cancer drug that is
  synthesized using
  chiral auxiliaries.




                                                   17

More Related Content

What's hot

Combinatorial Chemistry
 Combinatorial Chemistry Combinatorial Chemistry
Combinatorial Chemistry
Pradnya Gondane
 
Combinatorial chemistry
Combinatorial chemistryCombinatorial chemistry
Combinatorial chemistry. in drug discovery
Combinatorial chemistry. in drug discoveryCombinatorial chemistry. in drug discovery
Combinatorial chemistry. in drug discovery
ManjuJhakhar
 
Structure activity relationship 6
Structure activity relationship 6Structure activity relationship 6
Structure activity relationship 6
Abdul Samad
 
Chemical library
Chemical libraryChemical library
Physico-chemical Properties in Relation of Drug action
Physico-chemical Properties in Relation of Drug actionPhysico-chemical Properties in Relation of Drug action
Physico-chemical Properties in Relation of Drug action
Pradnya Gondane
 
combinatoral chemistry
combinatoral chemistrycombinatoral chemistry
combinatoral chemistry
Sonali Pimple
 
Drug likeness Properties
Drug likeness  PropertiesDrug likeness  Properties
Drug likeness Properties
narsaiahchelimela
 
23.optimizing access to target
23.optimizing access to target23.optimizing access to target
23.optimizing access to target
Abhijeet Kadam
 
Aquasomes
AquasomesAquasomes
Combinatorial chemistry
Combinatorial chemistryCombinatorial chemistry
Combinatorial chemistry
Afrinshaik1
 
Introduction of Medicinal chemistry
Introduction of Medicinal chemistryIntroduction of Medicinal chemistry
Introduction of Medicinal chemistry
vishvajitsinh Bhati
 
Combinatorial chemistry by santosh waghmare
Combinatorial chemistry by santosh waghmare Combinatorial chemistry by santosh waghmare
Combinatorial chemistry by santosh waghmare
Santosh Waghmare
 
Lipinski rule
Lipinski rule Lipinski rule
Lipinski rule
kholood adil
 
Combinatorial chemistry
Combinatorial chemistryCombinatorial chemistry
Combinatorial chemistry
Aartikamble7
 
General principles of structure activity relationship (sar)
General principles of structure activity relationship (sar)General principles of structure activity relationship (sar)
General principles of structure activity relationship (sar)
MANISH mohan
 
Combinatorial chemistry and high throughput screening
Combinatorial chemistry and high throughput screeningCombinatorial chemistry and high throughput screening
Combinatorial chemistry and high throughput screening
Anji Reddy
 
Structure activity relationship main
Structure activity relationship mainStructure activity relationship main
Structure activity relationship main
Sumit Kumar
 

What's hot (20)

Combinatorial Chemistry
 Combinatorial Chemistry Combinatorial Chemistry
Combinatorial Chemistry
 
Combinatorial chemistry
Combinatorial chemistryCombinatorial chemistry
Combinatorial chemistry
 
Combinatorial chemistry. in drug discovery
Combinatorial chemistry. in drug discoveryCombinatorial chemistry. in drug discovery
Combinatorial chemistry. in drug discovery
 
Structure activity relationship 6
Structure activity relationship 6Structure activity relationship 6
Structure activity relationship 6
 
Drug design
Drug designDrug design
Drug design
 
Chemical library
Chemical libraryChemical library
Chemical library
 
Lecture 1
Lecture 1Lecture 1
Lecture 1
 
Physico-chemical Properties in Relation of Drug action
Physico-chemical Properties in Relation of Drug actionPhysico-chemical Properties in Relation of Drug action
Physico-chemical Properties in Relation of Drug action
 
combinatoral chemistry
combinatoral chemistrycombinatoral chemistry
combinatoral chemistry
 
Drug likeness Properties
Drug likeness  PropertiesDrug likeness  Properties
Drug likeness Properties
 
23.optimizing access to target
23.optimizing access to target23.optimizing access to target
23.optimizing access to target
 
Aquasomes
AquasomesAquasomes
Aquasomes
 
Combinatorial chemistry
Combinatorial chemistryCombinatorial chemistry
Combinatorial chemistry
 
Introduction of Medicinal chemistry
Introduction of Medicinal chemistryIntroduction of Medicinal chemistry
Introduction of Medicinal chemistry
 
Combinatorial chemistry by santosh waghmare
Combinatorial chemistry by santosh waghmare Combinatorial chemistry by santosh waghmare
Combinatorial chemistry by santosh waghmare
 
Lipinski rule
Lipinski rule Lipinski rule
Lipinski rule
 
Combinatorial chemistry
Combinatorial chemistryCombinatorial chemistry
Combinatorial chemistry
 
General principles of structure activity relationship (sar)
General principles of structure activity relationship (sar)General principles of structure activity relationship (sar)
General principles of structure activity relationship (sar)
 
Combinatorial chemistry and high throughput screening
Combinatorial chemistry and high throughput screeningCombinatorial chemistry and high throughput screening
Combinatorial chemistry and high throughput screening
 
Structure activity relationship main
Structure activity relationship mainStructure activity relationship main
Structure activity relationship main
 

Viewers also liked

D9 Clube Presentation
D9 Clube PresentationD9 Clube Presentation
D9 Clube Presentation
d9worldwide
 
D9 presentation clube http://d9clube.mediatron.com.br/gilsonlondonuk10
D9 presentation clube http://d9clube.mediatron.com.br/gilsonlondonuk10D9 presentation clube http://d9clube.mediatron.com.br/gilsonlondonuk10
D9 presentation clube http://d9clube.mediatron.com.br/gilsonlondonuk10
Jordan Carter
 
Apresentação D9 Clube De Empreendedores
Apresentação D9 Clube De EmpreendedoresApresentação D9 Clube De Empreendedores
Apresentação D9 Clube De Empreendedores
D9Clubedeempreendedores
 
Les types de drogues et leurs effets par Christian Moretto
Les types de drogues et leurs effets par Christian MorettoLes types de drogues et leurs effets par Christian Moretto
Les types de drogues et leurs effets par Christian Moretto
LACT
 
Presentazione D9
Presentazione D9Presentazione D9
Presentazione D9
d9worldwide
 
Presentación D9 Clube
Presentación D9 ClubePresentación D9 Clube
Presentación D9 Clube
d9worldwide
 
D9 Clube Trader Esportivo
D9 Clube Trader EsportivoD9 Clube Trader Esportivo
D9 Clube Trader Esportivo
D9 Clube Trader Milionário
 
I marketslive português v1.3
I marketslive português v1.3I marketslive português v1.3
I marketslive português v1.3
coachguioliveira
 
Funciones base de datos
Funciones base de datosFunciones base de datos
Funciones base de datosjpalencia
 
Revolution of e commerce delivery services
Revolution of e commerce delivery servicesRevolution of e commerce delivery services
Revolution of e commerce delivery services
CleveronLtd
 
Kaizen 2.0 : growth beyond cost reduction
Kaizen 2.0 : growth beyond cost reductionKaizen 2.0 : growth beyond cost reduction
Kaizen 2.0 : growth beyond cost reduction
Bruno Fabiano
 
1st task unit 8 e commerce p2
1st task unit 8 e commerce p21st task unit 8 e commerce p2
1st task unit 8 e commerce p2
IronCheese
 
Apresentação Sobre Bitcoin na ACIJ
Apresentação Sobre Bitcoin na ACIJApresentação Sobre Bitcoin na ACIJ
Apresentação Sobre Bitcoin na ACIJ
Jaison Carvalho
 
E-Commerce Integration and Implementation Issues
E-Commerce Integration and Implementation IssuesE-Commerce Integration and Implementation Issues
E-Commerce Integration and Implementation IssuesNurul Izzah
 

Viewers also liked (15)

D9 Clube Presentation
D9 Clube PresentationD9 Clube Presentation
D9 Clube Presentation
 
D9 presentation clube http://d9clube.mediatron.com.br/gilsonlondonuk10
D9 presentation clube http://d9clube.mediatron.com.br/gilsonlondonuk10D9 presentation clube http://d9clube.mediatron.com.br/gilsonlondonuk10
D9 presentation clube http://d9clube.mediatron.com.br/gilsonlondonuk10
 
Apresentação D9 Clube De Empreendedores
Apresentação D9 Clube De EmpreendedoresApresentação D9 Clube De Empreendedores
Apresentação D9 Clube De Empreendedores
 
Les types de drogues et leurs effets par Christian Moretto
Les types de drogues et leurs effets par Christian MorettoLes types de drogues et leurs effets par Christian Moretto
Les types de drogues et leurs effets par Christian Moretto
 
Presentazione D9
Presentazione D9Presentazione D9
Presentazione D9
 
Presentación D9 Clube
Presentación D9 ClubePresentación D9 Clube
Presentación D9 Clube
 
D9 Clube Trader Esportivo
D9 Clube Trader EsportivoD9 Clube Trader Esportivo
D9 Clube Trader Esportivo
 
I marketslive português v1.3
I marketslive português v1.3I marketslive português v1.3
I marketslive português v1.3
 
Funciones base de datos
Funciones base de datosFunciones base de datos
Funciones base de datos
 
Revolution of e commerce delivery services
Revolution of e commerce delivery servicesRevolution of e commerce delivery services
Revolution of e commerce delivery services
 
Bitcoin
BitcoinBitcoin
Bitcoin
 
Kaizen 2.0 : growth beyond cost reduction
Kaizen 2.0 : growth beyond cost reductionKaizen 2.0 : growth beyond cost reduction
Kaizen 2.0 : growth beyond cost reduction
 
1st task unit 8 e commerce p2
1st task unit 8 e commerce p21st task unit 8 e commerce p2
1st task unit 8 e commerce p2
 
Apresentação Sobre Bitcoin na ACIJ
Apresentação Sobre Bitcoin na ACIJApresentação Sobre Bitcoin na ACIJ
Apresentação Sobre Bitcoin na ACIJ
 
E-Commerce Integration and Implementation Issues
E-Commerce Integration and Implementation IssuesE-Commerce Integration and Implementation Issues
E-Commerce Integration and Implementation Issues
 

Similar to D9 presentation

Application of Biological Assemblies in NanoBiotechnology PPt
Application of Biological Assemblies in NanoBiotechnology PPtApplication of Biological Assemblies in NanoBiotechnology PPt
Application of Biological Assemblies in NanoBiotechnology PPt
Zohaib HUSSAIN
 
Pharmaceutical chemistry
Pharmaceutical chemistryPharmaceutical chemistry
Pharmaceutical chemistry
Rupal Agarwal
 
pharmaceutical organic chemistry
pharmaceutical organic chemistry pharmaceutical organic chemistry
pharmaceutical organic chemistry
ayooy1992
 
_Lead_identification_and_optimization_.pptx
_Lead_identification_and_optimization_.pptx_Lead_identification_and_optimization_.pptx
_Lead_identification_and_optimization_.pptx
Ayodhya Paradhe
 
Drug Discovery subject (clinical research)
Drug Discovery subject (clinical research)Drug Discovery subject (clinical research)
Drug Discovery subject (clinical research)
Jannat985397
 
Pharmacophore
PharmacophorePharmacophore
Pharmacophore
sachin panwar
 
combinatorialchemistry-190501111508 (1).pptx
combinatorialchemistry-190501111508 (1).pptxcombinatorialchemistry-190501111508 (1).pptx
combinatorialchemistry-190501111508 (1).pptx
HarshitaGaur20
 
Aquasomes
AquasomesAquasomes
Aquasomes
rohan aggarwal
 
2. Lead Identification.pdf
2. Lead Identification.pdf2. Lead Identification.pdf
2. Lead Identification.pdf
Yogeshwary Bhongade
 
Combinatorial chemistry
Combinatorial chemistryCombinatorial chemistry
Combinatorial chemistry
Harendra Bisht
 
COMBINATORIAL CHEMISTRY- AN OVERVIEW ( FOR MEDICAL & PHARMA STUDENTS )
COMBINATORIAL CHEMISTRY- AN OVERVIEW ( FOR MEDICAL & PHARMA STUDENTS )COMBINATORIAL CHEMISTRY- AN OVERVIEW ( FOR MEDICAL & PHARMA STUDENTS )
COMBINATORIAL CHEMISTRY- AN OVERVIEW ( FOR MEDICAL & PHARMA STUDENTS )
Aaromal Satheesh
 
AQUASOMES (1).pptx
AQUASOMES (1).pptxAQUASOMES (1).pptx
AQUASOMES (1).pptx
Himadri priya Gogoi
 
Combinatorial Chemistry Sunil Yadav
Combinatorial Chemistry Sunil YadavCombinatorial Chemistry Sunil Yadav
Combinatorial Chemistry Sunil Yadav
Dr. Mahesh Kumar Kataria .
 
Combinatorial chemistry by Sunil Yadav SD Bihani College sri gangangar
Combinatorial chemistry by Sunil Yadav SD Bihani College sri gangangar Combinatorial chemistry by Sunil Yadav SD Bihani College sri gangangar
Combinatorial chemistry by Sunil Yadav SD Bihani College sri gangangar
sunilkamal1045
 
Micelle Drug Delivery System (Nanotechnology).pptx
Micelle Drug Delivery System (Nanotechnology).pptxMicelle Drug Delivery System (Nanotechnology).pptx
Micelle Drug Delivery System (Nanotechnology).pptx
Amity
 
Aquasomes.pptx.aquasome a novel drug carrier in pharmaceuticals
Aquasomes.pptx.aquasome a novel drug carrier in pharmaceuticalsAquasomes.pptx.aquasome a novel drug carrier in pharmaceuticals
Aquasomes.pptx.aquasome a novel drug carrier in pharmaceuticals
vaishnavimsdians
 
Molecular modelling and dcoking.pptx
Molecular modelling and dcoking.pptxMolecular modelling and dcoking.pptx
Molecular modelling and dcoking.pptx
12nikitaborade1
 
Combinatorial chemistry and HTS in lead identification.pdf
Combinatorial chemistry and HTS in lead identification.pdfCombinatorial chemistry and HTS in lead identification.pdf
Combinatorial chemistry and HTS in lead identification.pdf
Ayush Roy
 
Combinatorialchemistry
CombinatorialchemistryCombinatorialchemistry
Combinatorialchemistry
Gaurav raj soni
 
Hydrogels
HydrogelsHydrogels

Similar to D9 presentation (20)

Application of Biological Assemblies in NanoBiotechnology PPt
Application of Biological Assemblies in NanoBiotechnology PPtApplication of Biological Assemblies in NanoBiotechnology PPt
Application of Biological Assemblies in NanoBiotechnology PPt
 
Pharmaceutical chemistry
Pharmaceutical chemistryPharmaceutical chemistry
Pharmaceutical chemistry
 
pharmaceutical organic chemistry
pharmaceutical organic chemistry pharmaceutical organic chemistry
pharmaceutical organic chemistry
 
_Lead_identification_and_optimization_.pptx
_Lead_identification_and_optimization_.pptx_Lead_identification_and_optimization_.pptx
_Lead_identification_and_optimization_.pptx
 
Drug Discovery subject (clinical research)
Drug Discovery subject (clinical research)Drug Discovery subject (clinical research)
Drug Discovery subject (clinical research)
 
Pharmacophore
PharmacophorePharmacophore
Pharmacophore
 
combinatorialchemistry-190501111508 (1).pptx
combinatorialchemistry-190501111508 (1).pptxcombinatorialchemistry-190501111508 (1).pptx
combinatorialchemistry-190501111508 (1).pptx
 
Aquasomes
AquasomesAquasomes
Aquasomes
 
2. Lead Identification.pdf
2. Lead Identification.pdf2. Lead Identification.pdf
2. Lead Identification.pdf
 
Combinatorial chemistry
Combinatorial chemistryCombinatorial chemistry
Combinatorial chemistry
 
COMBINATORIAL CHEMISTRY- AN OVERVIEW ( FOR MEDICAL & PHARMA STUDENTS )
COMBINATORIAL CHEMISTRY- AN OVERVIEW ( FOR MEDICAL & PHARMA STUDENTS )COMBINATORIAL CHEMISTRY- AN OVERVIEW ( FOR MEDICAL & PHARMA STUDENTS )
COMBINATORIAL CHEMISTRY- AN OVERVIEW ( FOR MEDICAL & PHARMA STUDENTS )
 
AQUASOMES (1).pptx
AQUASOMES (1).pptxAQUASOMES (1).pptx
AQUASOMES (1).pptx
 
Combinatorial Chemistry Sunil Yadav
Combinatorial Chemistry Sunil YadavCombinatorial Chemistry Sunil Yadav
Combinatorial Chemistry Sunil Yadav
 
Combinatorial chemistry by Sunil Yadav SD Bihani College sri gangangar
Combinatorial chemistry by Sunil Yadav SD Bihani College sri gangangar Combinatorial chemistry by Sunil Yadav SD Bihani College sri gangangar
Combinatorial chemistry by Sunil Yadav SD Bihani College sri gangangar
 
Micelle Drug Delivery System (Nanotechnology).pptx
Micelle Drug Delivery System (Nanotechnology).pptxMicelle Drug Delivery System (Nanotechnology).pptx
Micelle Drug Delivery System (Nanotechnology).pptx
 
Aquasomes.pptx.aquasome a novel drug carrier in pharmaceuticals
Aquasomes.pptx.aquasome a novel drug carrier in pharmaceuticalsAquasomes.pptx.aquasome a novel drug carrier in pharmaceuticals
Aquasomes.pptx.aquasome a novel drug carrier in pharmaceuticals
 
Molecular modelling and dcoking.pptx
Molecular modelling and dcoking.pptxMolecular modelling and dcoking.pptx
Molecular modelling and dcoking.pptx
 
Combinatorial chemistry and HTS in lead identification.pdf
Combinatorial chemistry and HTS in lead identification.pdfCombinatorial chemistry and HTS in lead identification.pdf
Combinatorial chemistry and HTS in lead identification.pdf
 
Combinatorialchemistry
CombinatorialchemistryCombinatorialchemistry
Combinatorialchemistry
 
Hydrogels
HydrogelsHydrogels
Hydrogels
 

More from Sam Richard

Sam for ITS Dictator 2012
Sam for ITS Dictator 2012Sam for ITS Dictator 2012
Sam for ITS Dictator 2012
Sam Richard
 
Strange Meeting Olympians
Strange Meeting OlympiansStrange Meeting Olympians
Strange Meeting OlympiansSam Richard
 
D10 presentation
D10 presentationD10 presentation
D10 presentationSam Richard
 
Dulce et decorum est olympians
Dulce et decorum est olympiansDulce et decorum est olympians
Dulce et decorum est olympiansSam Richard
 
B5 presentation
B5 presentationB5 presentation
B5 presentation
Sam Richard
 
B2 Chemistry Presentation
B2 Chemistry PresentationB2 Chemistry Presentation
B2 Chemistry Presentation
Sam Richard
 
B3 presentation
B3 presentationB3 presentation
B3 presentation
Sam Richard
 

More from Sam Richard (20)

Sam for ITS Dictator 2012
Sam for ITS Dictator 2012Sam for ITS Dictator 2012
Sam for ITS Dictator 2012
 
D5 presentation
D5 presentationD5 presentation
D5 presentation
 
D1 presentation
D1 presentationD1 presentation
D1 presentation
 
D2 presentation
D2 presentationD2 presentation
D2 presentation
 
Strange Meeting
Strange MeetingStrange Meeting
Strange Meeting
 
Strange Meeting Olympians
Strange Meeting OlympiansStrange Meeting Olympians
Strange Meeting Olympians
 
Exposure
ExposureExposure
Exposure
 
The Show
The ShowThe Show
The Show
 
D10 presentation
D10 presentationD10 presentation
D10 presentation
 
D8 presentation
D8 presentationD8 presentation
D8 presentation
 
D4 presentation
D4 presentationD4 presentation
D4 presentation
 
D6 presentation
D6 presentationD6 presentation
D6 presentation
 
Dulce et decorum est olympians
Dulce et decorum est olympiansDulce et decorum est olympians
Dulce et decorum est olympians
 
B2 presentation
B2 presentationB2 presentation
B2 presentation
 
B4 presentation
B4 presentationB4 presentation
B4 presentation
 
B6 presentation
B6 presentationB6 presentation
B6 presentation
 
B7 presentation
B7 presentationB7 presentation
B7 presentation
 
B5 presentation
B5 presentationB5 presentation
B5 presentation
 
B2 Chemistry Presentation
B2 Chemistry PresentationB2 Chemistry Presentation
B2 Chemistry Presentation
 
B3 presentation
B3 presentationB3 presentation
B3 presentation
 

Recently uploaded

みなさんこんにちはこれ何文字まで入るの?40文字以下不可とか本当に意味わからないけどこれ限界文字数書いてないからマジでやばい文字数いけるんじゃないの?えこ...
みなさんこんにちはこれ何文字まで入るの?40文字以下不可とか本当に意味わからないけどこれ限界文字数書いてないからマジでやばい文字数いけるんじゃないの?えこ...みなさんこんにちはこれ何文字まで入るの?40文字以下不可とか本当に意味わからないけどこれ限界文字数書いてないからマジでやばい文字数いけるんじゃないの?えこ...
みなさんこんにちはこれ何文字まで入るの?40文字以下不可とか本当に意味わからないけどこれ限界文字数書いてないからマジでやばい文字数いけるんじゃないの?えこ...
名前 です男
 
LF Energy Webinar: Electrical Grid Modelling and Simulation Through PowSyBl -...
LF Energy Webinar: Electrical Grid Modelling and Simulation Through PowSyBl -...LF Energy Webinar: Electrical Grid Modelling and Simulation Through PowSyBl -...
LF Energy Webinar: Electrical Grid Modelling and Simulation Through PowSyBl -...
DanBrown980551
 
PCI PIN Basics Webinar from the Controlcase Team
PCI PIN Basics Webinar from the Controlcase TeamPCI PIN Basics Webinar from the Controlcase Team
PCI PIN Basics Webinar from the Controlcase Team
ControlCase
 
Artificial Intelligence for XMLDevelopment
Artificial Intelligence for XMLDevelopmentArtificial Intelligence for XMLDevelopment
Artificial Intelligence for XMLDevelopment
Octavian Nadolu
 
Communications Mining Series - Zero to Hero - Session 1
Communications Mining Series - Zero to Hero - Session 1Communications Mining Series - Zero to Hero - Session 1
Communications Mining Series - Zero to Hero - Session 1
DianaGray10
 
The Art of the Pitch: WordPress Relationships and Sales
The Art of the Pitch: WordPress Relationships and SalesThe Art of the Pitch: WordPress Relationships and Sales
The Art of the Pitch: WordPress Relationships and Sales
Laura Byrne
 
UiPath Test Automation using UiPath Test Suite series, part 6
UiPath Test Automation using UiPath Test Suite series, part 6UiPath Test Automation using UiPath Test Suite series, part 6
UiPath Test Automation using UiPath Test Suite series, part 6
DianaGray10
 
UiPath Test Automation using UiPath Test Suite series, part 5
UiPath Test Automation using UiPath Test Suite series, part 5UiPath Test Automation using UiPath Test Suite series, part 5
UiPath Test Automation using UiPath Test Suite series, part 5
DianaGray10
 
Uni Systems Copilot event_05062024_C.Vlachos.pdf
Uni Systems Copilot event_05062024_C.Vlachos.pdfUni Systems Copilot event_05062024_C.Vlachos.pdf
Uni Systems Copilot event_05062024_C.Vlachos.pdf
Uni Systems S.M.S.A.
 
Mind map of terminologies used in context of Generative AI
Mind map of terminologies used in context of Generative AIMind map of terminologies used in context of Generative AI
Mind map of terminologies used in context of Generative AI
Kumud Singh
 
Video Streaming: Then, Now, and in the Future
Video Streaming: Then, Now, and in the FutureVideo Streaming: Then, Now, and in the Future
Video Streaming: Then, Now, and in the Future
Alpen-Adria-Universität
 
Elizabeth Buie - Older adults: Are we really designing for our future selves?
Elizabeth Buie - Older adults: Are we really designing for our future selves?Elizabeth Buie - Older adults: Are we really designing for our future selves?
Elizabeth Buie - Older adults: Are we really designing for our future selves?
Nexer Digital
 
Pushing the limits of ePRTC: 100ns holdover for 100 days
Pushing the limits of ePRTC: 100ns holdover for 100 daysPushing the limits of ePRTC: 100ns holdover for 100 days
Pushing the limits of ePRTC: 100ns holdover for 100 days
Adtran
 
Microsoft - Power Platform_G.Aspiotis.pdf
Microsoft - Power Platform_G.Aspiotis.pdfMicrosoft - Power Platform_G.Aspiotis.pdf
Microsoft - Power Platform_G.Aspiotis.pdf
Uni Systems S.M.S.A.
 
Securing your Kubernetes cluster_ a step-by-step guide to success !
Securing your Kubernetes cluster_ a step-by-step guide to success !Securing your Kubernetes cluster_ a step-by-step guide to success !
Securing your Kubernetes cluster_ a step-by-step guide to success !
KatiaHIMEUR1
 
DevOps and Testing slides at DASA Connect
DevOps and Testing slides at DASA ConnectDevOps and Testing slides at DASA Connect
DevOps and Testing slides at DASA Connect
Kari Kakkonen
 
Alt. GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using ...
Alt. GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using ...Alt. GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using ...
Alt. GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using ...
James Anderson
 
Epistemic Interaction - tuning interfaces to provide information for AI support
Epistemic Interaction - tuning interfaces to provide information for AI supportEpistemic Interaction - tuning interfaces to provide information for AI support
Epistemic Interaction - tuning interfaces to provide information for AI support
Alan Dix
 
FIDO Alliance Osaka Seminar: The WebAuthn API and Discoverable Credentials.pdf
FIDO Alliance Osaka Seminar: The WebAuthn API and Discoverable Credentials.pdfFIDO Alliance Osaka Seminar: The WebAuthn API and Discoverable Credentials.pdf
FIDO Alliance Osaka Seminar: The WebAuthn API and Discoverable Credentials.pdf
FIDO Alliance
 
Observability Concepts EVERY Developer Should Know -- DeveloperWeek Europe.pdf
Observability Concepts EVERY Developer Should Know -- DeveloperWeek Europe.pdfObservability Concepts EVERY Developer Should Know -- DeveloperWeek Europe.pdf
Observability Concepts EVERY Developer Should Know -- DeveloperWeek Europe.pdf
Paige Cruz
 

Recently uploaded (20)

みなさんこんにちはこれ何文字まで入るの?40文字以下不可とか本当に意味わからないけどこれ限界文字数書いてないからマジでやばい文字数いけるんじゃないの?えこ...
みなさんこんにちはこれ何文字まで入るの?40文字以下不可とか本当に意味わからないけどこれ限界文字数書いてないからマジでやばい文字数いけるんじゃないの?えこ...みなさんこんにちはこれ何文字まで入るの?40文字以下不可とか本当に意味わからないけどこれ限界文字数書いてないからマジでやばい文字数いけるんじゃないの?えこ...
みなさんこんにちはこれ何文字まで入るの?40文字以下不可とか本当に意味わからないけどこれ限界文字数書いてないからマジでやばい文字数いけるんじゃないの?えこ...
 
LF Energy Webinar: Electrical Grid Modelling and Simulation Through PowSyBl -...
LF Energy Webinar: Electrical Grid Modelling and Simulation Through PowSyBl -...LF Energy Webinar: Electrical Grid Modelling and Simulation Through PowSyBl -...
LF Energy Webinar: Electrical Grid Modelling and Simulation Through PowSyBl -...
 
PCI PIN Basics Webinar from the Controlcase Team
PCI PIN Basics Webinar from the Controlcase TeamPCI PIN Basics Webinar from the Controlcase Team
PCI PIN Basics Webinar from the Controlcase Team
 
Artificial Intelligence for XMLDevelopment
Artificial Intelligence for XMLDevelopmentArtificial Intelligence for XMLDevelopment
Artificial Intelligence for XMLDevelopment
 
Communications Mining Series - Zero to Hero - Session 1
Communications Mining Series - Zero to Hero - Session 1Communications Mining Series - Zero to Hero - Session 1
Communications Mining Series - Zero to Hero - Session 1
 
The Art of the Pitch: WordPress Relationships and Sales
The Art of the Pitch: WordPress Relationships and SalesThe Art of the Pitch: WordPress Relationships and Sales
The Art of the Pitch: WordPress Relationships and Sales
 
UiPath Test Automation using UiPath Test Suite series, part 6
UiPath Test Automation using UiPath Test Suite series, part 6UiPath Test Automation using UiPath Test Suite series, part 6
UiPath Test Automation using UiPath Test Suite series, part 6
 
UiPath Test Automation using UiPath Test Suite series, part 5
UiPath Test Automation using UiPath Test Suite series, part 5UiPath Test Automation using UiPath Test Suite series, part 5
UiPath Test Automation using UiPath Test Suite series, part 5
 
Uni Systems Copilot event_05062024_C.Vlachos.pdf
Uni Systems Copilot event_05062024_C.Vlachos.pdfUni Systems Copilot event_05062024_C.Vlachos.pdf
Uni Systems Copilot event_05062024_C.Vlachos.pdf
 
Mind map of terminologies used in context of Generative AI
Mind map of terminologies used in context of Generative AIMind map of terminologies used in context of Generative AI
Mind map of terminologies used in context of Generative AI
 
Video Streaming: Then, Now, and in the Future
Video Streaming: Then, Now, and in the FutureVideo Streaming: Then, Now, and in the Future
Video Streaming: Then, Now, and in the Future
 
Elizabeth Buie - Older adults: Are we really designing for our future selves?
Elizabeth Buie - Older adults: Are we really designing for our future selves?Elizabeth Buie - Older adults: Are we really designing for our future selves?
Elizabeth Buie - Older adults: Are we really designing for our future selves?
 
Pushing the limits of ePRTC: 100ns holdover for 100 days
Pushing the limits of ePRTC: 100ns holdover for 100 daysPushing the limits of ePRTC: 100ns holdover for 100 days
Pushing the limits of ePRTC: 100ns holdover for 100 days
 
Microsoft - Power Platform_G.Aspiotis.pdf
Microsoft - Power Platform_G.Aspiotis.pdfMicrosoft - Power Platform_G.Aspiotis.pdf
Microsoft - Power Platform_G.Aspiotis.pdf
 
Securing your Kubernetes cluster_ a step-by-step guide to success !
Securing your Kubernetes cluster_ a step-by-step guide to success !Securing your Kubernetes cluster_ a step-by-step guide to success !
Securing your Kubernetes cluster_ a step-by-step guide to success !
 
DevOps and Testing slides at DASA Connect
DevOps and Testing slides at DASA ConnectDevOps and Testing slides at DASA Connect
DevOps and Testing slides at DASA Connect
 
Alt. GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using ...
Alt. GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using ...Alt. GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using ...
Alt. GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using ...
 
Epistemic Interaction - tuning interfaces to provide information for AI support
Epistemic Interaction - tuning interfaces to provide information for AI supportEpistemic Interaction - tuning interfaces to provide information for AI support
Epistemic Interaction - tuning interfaces to provide information for AI support
 
FIDO Alliance Osaka Seminar: The WebAuthn API and Discoverable Credentials.pdf
FIDO Alliance Osaka Seminar: The WebAuthn API and Discoverable Credentials.pdfFIDO Alliance Osaka Seminar: The WebAuthn API and Discoverable Credentials.pdf
FIDO Alliance Osaka Seminar: The WebAuthn API and Discoverable Credentials.pdf
 
Observability Concepts EVERY Developer Should Know -- DeveloperWeek Europe.pdf
Observability Concepts EVERY Developer Should Know -- DeveloperWeek Europe.pdfObservability Concepts EVERY Developer Should Know -- DeveloperWeek Europe.pdf
Observability Concepts EVERY Developer Should Know -- DeveloperWeek Europe.pdf
 

D9 presentation

  • 1. D.9 Drug Design By: Sam, Rob, and Farah 1
  • 2. D.9 Drug Design By: Sam, Rob, and Farah 1
  • 3. D.9.1 Discuss the use of a compound library in drug design. • A compound library is a collection of stored chemicals, typically used in drug discovery high-throughput screening and industrial manufacturing. • Each chemical has all of its chemical information like its chemical structure, chemical properties, and physical properties, stored in a database. • If a pharmaceutical chemist is in need of a chemical to perform a particular function, he or she can search the electronic compound library database. • This eliminates the synthesizing and the individual evaluation in the laboratory of a large number of related compounds. Large numbers of related compounds can be created quickly. • This approach saves money and time.
  • 4. D.9.2 Explain the use of combinatorial and parallel chemistry to synthesize new drugs. • Combinatorial Chemistry • Combinatorial chemistry involves the rapid synthesis or computer simulation of a large number of different but structurally related molecules or materials. • Used to synthesize a large number of different compounds. • Produces an electronic database or combinatorial library. • Used to mass produce drugs by two solid-phase synthesis.
  • 5. D.9.2 Explain the use of combinatorial and parallel chemistry to synthesize new drugs. Solid-Phase Synthesis • Starting material is covalently bonded to small polystyrene beads • The beads are reacted with one another and then split and reacted with new substances to make new combination of molecules • Produced a wide range of molecules • The products are then purified by filtering of the beads and washing • Used to build proteins (polypeptides) • This method is fully automated and uses robotics
  • 6. D.9.2 Explain the use of combinatorial and parallel chemistry to synthesize new drugs. • Sets of individual compounds are then prepared simultaneously by reacting with a number of different reagents in arrays of physically separate reaction vessels or micro- compartments w/o interchange of intermediates during the assembly process • This allows a smaller, more focused library than that obtained with comb. chemistry • First step towards producing larger yields of materials identified from screening tests • They can then be fully characterized w/o need for huge and laborious identification procedures
  • 7. D.9.2 Explain the use of combinatorial and parallel chemistry to synthesize new drugs. Parallel Synthesis • Used to produce smaller, more focused compound libraries • An alternative technique to complement combinatorial chemistry • Still uses solid-phase chemistry but on a larger scale than comb. chemistry • Advantage: all intermediates and products are generated separately • Involves a synthesis of a highly reactive intermediates
  • 8. D.9.3 Describe how computers are used in Drug Design • It would be impossible to test millions of molecules in a lab against any given target, but the computerized screening process helps in designating a small set of molecules that can then be tested in a wet lab. • “In-Silico Drug Design” is a series of methods in which the computer assists in the identification and development of medicine and drugs. There are several methods, each with a different purpose/ application
  • 9. D.9.3 Describe how computers are used in Drug Design They include:  Molecular Docking and Virtual Screening: the ability to predict binding conformations and affinities of millions of molecules without the need of a single synthetic step  Molecular Dynamics: the prediction of the evolution of molecular systems over time, the study of protein conformation, protein-protein interactions, the simulation of biological membranes.  Quantum Mechanics: the study of chemical reactions, the effects of substitutions on electronic properties and reactivity of molecules  QSAR: Quantitative structure-activity relationship. The ability of predicting biological properties of molecules without even the need of knowing their target  Homology Modeling: predicting the structures of proteins that has not been yet crystallized
  • 10. D.9.3 Describe how computers are used in Drug Design • One example is the CSIR Bio-Suite • The Indian CSIR (Council for Scientific and Industrial Research) developed the “Bio- Suite” • a software tool to aid in the drug discovery process.
  • 11. D.9.4. Discuss how the polarity of a molecule can be modified to increase its aqueous solubility and how this facilitates its distribution around the body • Most medicines/drugs are fairly complex organic molecules with low polarity. • Tend to be insoluble in water and other polar environments in the body, which greatly limits their capacity as a medicine. • To increase solubility, they can be administered as an ionic salt.
  • 12. D.9.4. Discuss how the polarity of a molecule can be modified to increase its aqueous solubility and how this facilitates its distribution around the body • If the molecule contains amines, then they can be converted into their hydrochloride acid • This can be seen in the reaction of ammonia and hydrochloric acid.
  • 13. D.9.4. Discuss how the polarity of a molecule can be modified to increase its aqueous solubility and how this facilitates its distribution around the body • An example of such a drug is Fluoxetine Hydrochloride, more commonly known as Prozac • The opiates contain an amine group and can therefore be administered as their hydrochloride salt.
  • 14. D.9.4. Discuss how the polarity of a molecule can be modified to increase its aqueous solubility and how this facilitates its distribution around the body • Another example is Diamorphine (Heroine) • The white powder is actually Diacetylmorphine hydrochloride, making it soluble and possible to inject into the body.
  • 15. D.9.4. Discuss how the polarity of a molecule can be modified to increase its aqueous solubility and how this facilitates its distribution around the body • The same concept applies to drugs that contain a carboxylic acid group. These drugs can be made polar by converting them into their anion and administering them as a sodium or calcium salt. • Take soluble aspirin for example. The anion of aspirin enters the body and returns to its unionized form once it has reached a strong acidic part of the body (the stomach)
  • 16. D.9.5 Describe the use of chiral auxiliaries to form the desired enantiomer. • Traditionally, the synthesis of an optically active compound normally produces a racemic mixture of the two enantiomers. The mixture has to be separated into the two isomers. • Recently, a technique using chiral auxiliaries has made it possible to synthesize just the desired isomer. • A chiral auxiliary is an optically active chemical compound or unit that is temporarily incorporated into organic synthesis so that it can be carried out asymmetrically with the selective formation of one of two enantiomers. • This is useful as enantiomers have identical chemical properties in relation to non-chiral reagents and cannot therefore be easily chemically separated. • However, because of the different properties of enantiomers in biochemical reactions, separation is vital.
  • 17. D.9.5 Describe the use of chiral auxiliaries to form the desired enantiomer. • The chiral auxiliary attaches itself to the non-chiral molecule to create the stereochemical conditions necessary to force the reaction to follow a certain path. • Once the new molecule has been formed, the auxiliary can be taken off (recycled) to leave the desired enantiomer.
  • 18. D.9.5 Describe the use of chiral auxiliaries to form the desired enantiomer. • Taxol is an anti- cancer drug that is synthesized using chiral auxiliaries. 17